• Company Information
  • About the Report
  • Documents
  • Outstanding Payments (MSME)
  • Complaints
  • Directors
  • Same Address Companies
  • Charges
  • Contact Details
  • Products & Services
  • Balance Sheet
  • Profit & Loss
  • Fund Raising
  • Shareholders & Investors
  • Board Meetings
  • Auditors

PHARMANZA HERBAL PRIVATE LIMITED

CIN: U24236GJ2004PTC044806

PHARMANZA HERBAL PRIVATE LIMITED (CIN: U24236GJ2004PTC044806) is a Private company incorporated on 27 Sep 2004. It is classified as Non-government company and is registered at Registrar of Companies, Ahmedabad. Its authorized share capital is Rs. 49000000.00 and its paid up capital is Rs. 32350000.00.

PHARMANZA HERBAL PRIVATE LIMITED's Annual General Meeting (AGM) was last held on 30 Sep 2023. and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 2023-03-31.PHARMANZA HERBAL PRIVATE LIMITED's NIC code is 2423 (which is part of its CIN). As per the NIC code, it is inolved in Manufacture of pharmaceuticals, medicinal chemicals and botanical products.

Directors of PHARMANZA HERBAL PRIVATE LIMITED are BHUPENDRABHAI JIVABHAI PATEL, LAL LACHHMANDAS HINGORANI, CHETNABEN VIJAYKUMAR SHAH, HARDIK RAVINDRABHAI PATEL, and ASHISH SURENDRABHAI PATEL.

PHARMANZA HERBAL PRIVATE LIMITED's Corporate Identification Number (CIN) is U24236GJ2004PTC044806 and its registration number is 44806. Users may contact PHARMANZA HERBAL PRIVATE LIMITED on its Email address - [email protected]. Registered address of PHARMANZA HERBAL PRIVATE LIMITED is PLOT NO 214, NEAR VADADLA PATIYA BORSAD-TARAPUR ROAD , KANIY,ANAND, Gujarat, India - 388435.

Current status of PHARMANZA HERBAL PRIVATE LIMITED is - Active.

Basic Information

  • CIN
  • Name
  • Listed on Stock Exchange
  • Company Status
  • ROC
  • Registration Number
  • Company Category
  • Company Sub Category
  • Class of Company
  • Date of Incorporation
  • Age of Company
  • Activity
  • Number of Members

Annual Compliance Status

  • Date of Last Annual General Meeting
  • Date of Last Filed Balance Sheet

Key Numbers

  • Authorised Share Capital
  • Paid-up Share Capital
  • Total Assets
  • Revenue
  • Profit
  • Salaries & Other Employee Benefit Expenses
Want to see how this company compares within its industry or analyse broader market trends?
Explore Prime Research for Industry & Economic Insights

Previous Names

Previous CINs

ZaubaCorp's company report for PHARMANZA HERBAL includes audited balance sheets, profit & loss statements, charges, director history, shareholding and related-party transactions, compiled from official MCA filings — delivered as PDF and Excel.

Purchase Report

All companies in India are required to file various documents like financials, loan agreements, list of shareholders, details of directors, details of funding rounds and a lot more. These documents are credible and offer incredible insights about a company. However, understanding a company by viewing its documents is an extremely difficult and time consuming process.

Our reports are designed to save you significant time by surfacing key information easily and structuring it in a way that helps in your research.

Understanding the key findings and information in our reports can be crucial if you're a customer, vendor, investor, partner or even a potential employee of PHARMANZA HERBAL

Purchase full report of PHARMANZA HERBAL

Companies are required to file half yearly returns showing payments due to Micro & Small Enterprises that have been delayed more than 45 days. This information is crucial to understand if PHARMANZA HERBAL pays its vendors promptly. When seen over a period of time, this information could show if the company has slowed down in making payments to its small vendors. This information is available only if the company has filed its half yearly returns with the registrar of companies.

Filing Type As On Amount Due to MSME Current Liabilities Ratio to Current Liabilities Reasons for Delay

This section contains details of investor complaints or serious complaints filed with the registrar of companies. This information can surface potential red flags about a company.

Director Complaints
Date DIN Cessation Date Cessation Reason Complaint
Serious Complaints
Date Complaint Other Details
Investor Complaints & Other Complaints
Date Complaint Type Complaint Sub Type Particulars of Secutiries Period Complaint Other Details

Current Directors & Key Managerial Personnel of PHARMANZA HERBAL
DIN Director Name Designation Appointment Date
01785019 BHUPENDRABHAI JIVABHAI PATEL Director 2013-04-01
01785030 LAL LACHHMANDAS HINGORANI Director 2018-03-01
10417078 CHETNABEN VIJAYKUMAR SHAH Additional Director 2023-12-11
00357469 HARDIK RAVINDRABHAI PATEL Director 2013-04-01
01309384 ASHISH SURENDRABHAI PATEL Director 2004-09-27
Past Directors & Key Managerial Personnel of PHARMANZA HERBAL
DIN Director Name Designation Appointment Date Cessation
01785019 BHUPENDRABHAI JIVABHAI PATEL Director - 2013-04-01
01785019 BHUPENDRABHAI JIVABHAI PATEL Whole-time director - 2024-01-04
01785030 LAL LACHHMANDAS HINGORANI Managing Director - 2013-04-01
01785030 LAL LACHHMANDAS HINGORANI Whole-time director - 2018-03-01
00357469 HARDIK RAVINDRABHAI PATEL Director - 2013-04-01
00357469 HARDIK RAVINDRABHAI PATEL Whole-time director - 2024-01-04
00357482 RAVINDRABHAI PURSHOTTAMBHAI PATEL Additional Director - 2014-09-30
00357482 RAVINDRABHAI PURSHOTTAMBHAI PATEL Director - 2020-09-28
01309478 SURENDRA RATILAL PATEL Additional Director - 2014-09-30
01309478 SURENDRA RATILAL PATEL Whole-time director - 2020-01-10
01785015 VIJAYKUMAR CHAMPAKLAL SHAH Director - 2013-04-01
01785015 VIJAYKUMAR CHAMPAKLAL SHAH Managing Director - 2018-03-01
Other Directorships of BHUPENDRABHAI JIVABHAI PATEL
Company Name CIN Designation Appointment Date Cessation
PHARMANZA (INDIA) PRIVATE LIMITED U24230GJ2009PTC055895 Director - 2013-04-01
PHARMANZA (INDIA) PRIVATE LIMITED U24230GJ2009PTC055895 Managing Director 2013-04-01 Ongoing
MEEK PHARMA PRIVATE LIMITED U24230UR2005PTC000876 Director 2005-08-01 Ongoing
Other Directorships of LAL LACHHMANDAS HINGORANI
Company Name CIN Designation Appointment Date Cessation
VERMED PHARMACEUTICALS LLP AAL-9424 Designated Partner 2018-02-07 Ongoing
TRUE LIFE WONDERS LLP AAM-5489 Partner 2019-06-21 Ongoing
BACIL PHARMA LTD L24200MH1987PLC043427 Director - 2012-02-24
PHARMANZA (INDIA) PRIVATE LIMITED U24230GJ2009PTC055895 Director 2009-01-15 Ongoing
INSAT PHARMA PRIVATE LIMITED U24230GJ2022PTC129967 Additional Director - 2023-09-21
INSAT PHARMA PRIVATE LIMITED U24230GJ2022PTC129967 Director 2022-05-30 Ongoing
SHELLAC AND FOREST PRODUCTS EXPORT PROMOTION COUNCIL U91110WB1957NPL023474 Director 2020-12-30 Ongoing
Other Directorships of CHETNABEN VIJAYKUMAR SHAH
Company Name CIN Designation Appointment Date Cessation
Other Directorships of HARDIK RAVINDRABHAI PATEL
Company Name CIN Designation Appointment Date Cessation
VERMED PHARMACEUTICALS LLP AAL-9424 Partner 2018-02-07 Ongoing
ASN HOTEL LLP AAN-6129 Designated Partner 2023-09-20 Ongoing
PHARMANZA (INDIA) PRIVATE LIMITED U24230GJ2009PTC055895 Director - 2013-04-01
PHARMANZA (INDIA) PRIVATE LIMITED U24230GJ2009PTC055895 Whole-time director 2013-04-01 Ongoing
INSAT PHARMA PRIVATE LIMITED U24230GJ2022PTC129967 Additional Director - 2023-09-21
INSAT PHARMA PRIVATE LIMITED U24230GJ2022PTC129967 Director 2022-05-30 Ongoing
ATLAS CABLES AND ACCESSORIES PRIVATE LIMITED U31300GJ2010PTC059467 Director 2010-02-08 Ongoing
SHREE HOSPITALITY PRIVATE LIMITED U55101GJ2008PTC054235 Additional Director - 2014-09-30
SHREE HOSPITALITY PRIVATE LIMITED U55101GJ2008PTC054235 Director 2014-09-30 Ongoing
WESTERN INDIA SEA BRINES PVT LTD U74999GJ1995PTC025084 Director 2005-06-10 Ongoing
Other Directorships of RAVINDRABHAI PURSHOTTAMBHAI PATEL
Other Directorships of ASHISH SURENDRABHAI PATEL
Company Name CIN Designation Appointment Date Cessation
SACKIT COMMERCIAL SERVICES LLP AAC-2549 Designated Partner 2014-04-10 Ongoing
VERMED PHARMACEUTICALS LLP AAL-9424 Partner 2018-02-07 Ongoing
TRUE LIFE WONDERS LLP AAM-5489 Designated Partner 2018-05-03 Ongoing
VOLTAMP TRANSFORMERS LIMITED L31100GJ1967PLC001437 Additional Director - 2019-08-14
VOLTAMP TRANSFORMERS LIMITED L31100GJ1967PLC001437 Director - 2022-02-22
NISOL MANUFACTURING COMPANY PRIVATE LIMITED U16009GJ2007PTC051026 Managing Director 2007-06-04 Ongoing
Other Directorships of SURENDRA RATILAL PATEL
Company Name CIN Designation Appointment Date Cessation
NISOL MANUFACTURING COMPANY PRIVATE LIMITED U16009GJ2007PTC051026 Director - 2008-09-05
Other Directorships of VIJAYKUMAR CHAMPAKLAL SHAH
Company Name CIN Designation Appointment Date Cessation
PHARMANZA (INDIA) PRIVATE LIMITED U24230GJ2009PTC055895 Director - 2023-10-29
MEEK PHARMA PRIVATE LIMITED U24230UR2005PTC000876 Additional Director - 2008-09-25
MEEK PHARMA PRIVATE LIMITED U24230UR2005PTC000876 Director - 2023-11-21

CIN Company Name Company Address

Charge ID Charge Creation Date Charge Modification Date Charge Closure Date Assets Under Charge Amount Charge Holder
10578563 2015-06-19 - 2016-12-29 6,475,000.00 Bank of India
80003980 2005-04-29 2012-02-24 2014-01-24 35,000,000.00 BANK OF INDIA (ALKAPURI BRANCH)
100626225 2022-11-03 - - 47,500,000.00 HDFC BANK LIMITED

  • Email ID
  • Website
  • Address

This information shows products and services that contribute highest to the company's revenue. Analysing this over a period of time can show the evolution of the company in terms of the products and services it offers.

Financial Year Business Activity Code Business Activity Description Percentage of Turnover

Financial information is availalbe only if it has been filed by the company. If the company has not filed its returns, financials for the defaulting period will not be available.

2024-03-31 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31 2017-03-31 2016-03-31 2015-03-31 2014-03-31 2013-03-31 2012-03-31
Download Audited Financials
EQUITY AND LIABILITIES
   Shareholder's funds
      Share Capital
      Reserves & Surplus
      Money Received Against Share Warrants
   Share Application Money Pending Allotment
   Non-current Liabilities
      Long-term borrowings
      Deferred tax liabilities
      Other Long Term Liabilities
      Long Term Provisions
   Current Liabilities
      Short-term borrowings
      Trade Payables
      Other Current Liabilities
      Short Term Provisions
Total Equity and Liabilities
ASSETS
   Non-current Assets
      Fixed Assets
         Tangible Assets
         Intangible Assets
         Capital Work In Progress
         Intangible Assets Under Development
      Non-current Investments
      Deferred Tax Assets (net)
      Long-term Loans & Advances
      Other Non-current Assets
   Current Assets
      Current Investments
      Inventories
      Trade receivables
      Cash & Cash Equivalents
      Short-term Loans & Advances
      Other Current Assets
Total Assets

Financial information is availalbe only if it has been filed by the company. If the company has not filed its returns, financials for the defaulting period will not be available.

2024-03-31 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31 2017-03-31 2016-03-31 2015-03-31 2014-03-31 2013-03-31 2012-03-31
Download Audited Financials
REVENUE FROM OPERATIONS
   Domestic Turnover
      Sale of Goods Manufactured
      Sale of Goods Traded
      Sale of Supple of Services
   Export Turnover
      Sale of Goods Manufactured
      Sale of Goods Traded
      Sale or Supply of Services
   Other Income
Total Revenue From Operations
EXPENSES
   Cost of Materials Consumed
   Purchases of Stock in Trade
   Change in Inventories of
      Finished Goods
      Work in Progress
      Stock in Trade
   Employee benefit Expenses
   Managerial Remuneration
   Payment to Auditors
   Insurance Expenses
   Power & Fuel
   Finance Cost
   Depreciation & Amortization Expenses
   Other Expenses
Total Expenses
Profit before Exceptional Items, Extraordinary Items and Tax
   Exceptional Items
Profit before Extraordinary items and Tax
   Extraordinary Items
Profit before Tax
   Tax Expense
      Current Tax
      Deferred Tax
Profit/Loss after Tax from Continuing Operations
Profit/Loss after Tax from Discontinuing Operations
   Tax Expense of Discontinuing Operations
Total Profit/Loss
Earnings per Equity Share (EPS) before Extraordinary Items
   Basic
   Diluted
Earnings per Equity Share (EPS) after Extraordinary Items
   Basic
   Diluted

This section contains details of cash raised by allocation of equity or debentures. All types of fund raising acitivity is listed here including funding raised through Venture Capital. Attachments would contain further details of the fund raising activity including names of the investors. This information is available only if the company has raised funds through cash allotment of equity or debentures.

Date of Allotment Securities Alloted Terms Number of Securities Nominal Amount Premium Amount Due & Payable Premium Amount Paid Total Discount Amount to be Paid on Calls (Excluding Premium) Attachments

This section contains list of associate companies and joint ventures as per the most recently available annual returns. This information would not be available if the company has not filed annual returns at all or it does not have any subsidiaries or joint ventures.

Company Identifier Name Percentage of Shares Held

This section contains list of board resolutions reported by the company to the Registrar of Companies.

Date of Filing Date of Dispatch of Notice Date of Passing Resolution Section (Companies Act 2013) Section (Companies Act 1956) Subject Matter of Resolution Resolution Agreed By Resolution Type Additional Documents

This section contains auditors of a company over the years. This information is available if the company has filed their annual returns with the Registrar of Companies.

Financial Year Name of Auditor or Firm PAN of Auditor or Firm Membership Number / Registration Number Name of Auditor Signing Report Membership Number of Auditor Signing Report

As on: 2026-07-13

Is this information out of date or is there a discrepancy with the information? Click on the Update Information button below and we will review the information.

Purchase our hand crafted financial report for $ 9.99